Suvoda Commits to SCRS Global Impact Partner Program
August 13, 2024 – The Society for Clinical Research Sites (SCRS) proudly welcomes Suvoda, a global clinical trial technology company specializing in complex studies, to its Global Impact Partner (GIP) program.
Operating in more than 85 countries with research sites in thousands of locations, Suvoda has conducted over 1,500 clinical trials focusing mainly on oncology, rare diseases, and CNS. The company’s single platform delivers eConsent, Interactive Response Technology (IRT), and electronic Clinical Outcome Assessment (eCOA).
The SCRS GIP program fosters a synergistic partnership between industry leaders and research sites to develop site-focused initiatives and solutions. By joining the GIP program, Suvoda will collaborate with research sites and industry partners, offering global expertise in alignment with the program’s mission.
“As clinical trials increase in complexity and new technologies emerge, we are excited to work with SCRS and its member sites to transform the patient journey in a clinical trial,” said Rob Hummel, President and Chief Operating Officer at Suvoda. “Our focus is on making our products more intuitive, robust and streamlined so that site teams have the tools they need to calmly guide their patients through some of the most challenging moments of their lives.”
“Suvoda is a valuable addition to our passionate GIP community, bringing specialized experience and a strong commitment to clinical research efficiency,” commented Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Suvoda’s focus on optimizing clinical trial technology and processes, especially in complex therapeutic areas, is commendable. Working closely with SCRS’ global network of research sites and industry leaders, Suvoda will help advance site-centric solutions that address unique challenges in life-changing trials.”
The SCRS GIP program offers industry sponsors, CROs, service providers and research sites an opportunity to align with SCRS’ mission of ensuring site sustainability. Learn more about the GIP program at myscrs.org/industry-partnerships/global-impact-partners.
About Suvoda
Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,500 trials across 85 countries. To learn more, visit suvoda.com. Follow Suvoda on LinkedIn.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
